Injectable codeine is obtainable for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this can result in nonimmune mast-mobile degranulation and resulting anaphylactoid response. Codeine suppositories will also be marketed in a few international locations. In Eire, new restrictions came into effect on 1 August 2010[ninety] relating to https://codeingil.com/